Asston Pharmaceuticals (APL) Share Price near 52-week high after 4.99% rise

Asston Pharmaceuticals Share Price is Rs 124.46, up 4.99%, and trading close to its 52-week high. The company’s market capitalisation stands at Rs 129.48 crore, while today’s move keeps Asston Pharmaceuticals Ltd. (APL) firmly on the radar in stock news and share price watchlists.

Asston Pharmaceuticals Share Price is at Rs 124.46 as of 22 October 2026 at 9:52 AM IST, up 4.99% from the previous close of Rs 118.54. The stock is trading near its 52-week high and the company’s market capitalisation is Rs 129.48 crore. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Asston Pharmaceuticals Share Price Today, the move is relevant because it places the stock close to its one-year high while also keeping valuation, profitability and sector positioning in focus. Asston Pharmaceuticals Stock News is therefore centred on verified price action rather than any stated trigger.

Asston Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 124.46
Previous Close	Rs 118.54
Today's Move	+Rs 5.92 (+4.99%)
Open	Rs 123.14
High	Rs 124.46
Low	Rs 118
Market Capitalisation	Rs 129.48 crore

Asston Pharmaceuticals Ltd. (APL) traded at Rs 124.46 versus the previous close of Rs 118.54, a rise of 4.99%. The stock opened at Rs 123.14, reached a high of Rs 124.46 and touched a low of Rs 118.

Asston Pharmaceuticals Share Price Today shows a firm intraday move from the opening price of Rs 123.14 to a high of Rs 124.46, with the low at Rs 118. The stock is currently at Rs 124.46, which is Rs 5.92 above the previous close of Rs 118.54. That translates into a 4.99% increase, making the share price movement clear in the context of the current 52-week high event. Asston Pharmaceuticals Share Price also sits at the top of the day’s range so far, which keeps Asston Pharmaceuticals Share Price News focused on verified price action and the company’s proximity to its yearly high. On a simple market update basis, this is a notable Asston Pharmaceuticals Share Price live move for a stock with a market cap below Rs 150 crore.

For investors following Asston Pharmaceuticals Share Price Update and Asston Pharmaceuticals Share Price News, the key point is the proximity to the 52-week high rather than any inferred cause. The latest Univest figures confirm the event, but they do not point to a stock-specific announcement. That makes the current move useful for watchlist tracking, especially when viewed alongside the company’s valuation and sector context. Asston Pharmaceuticals Share Price Today remains the main headline, while Asston Pharmaceuticals Stock Performance can be assessed only from the verified numbers available here.

Asston Pharmaceuticals Ltd. (APL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 129.48 crore
P/E Ratio	33.51x
P/B Ratio	1.96x
ROE	50.56%
ROCE	42.64%
EPS	Rs 3.54
Book Value Per Share	Rs 60.43
Dividend Yield	0%

Asston Pharmaceuticals Ltd. (APL) fundamental metrics show P/E 33.51x, P/B 1.96x, ROE 50.56%, ROCE 42.64%. These figures provide context only and are not a buy or sell signal.

Asston Pharmaceuticals Ltd. has a market capitalisation of Rs 129.48 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 33.51x, P/B at 1.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 50.56% and ROCE of 42.64%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.54, book value per share of Rs 60.43, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.67x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	33.51x
Benchmark Median P/E	26.67x
Benchmark Average P/E	38.8x
Benchmark P/E Range	0x to 616.23x
Company P/B Ratio	1.96x
Benchmark Median P/B	2.7x
Company ROE	50.56%
Benchmark Median ROE	11.23%
Company ROCE	42.64%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 129.48 crore
Benchmark Median Market Cap	Rs 786.06 crore

Asston Pharmaceuticals Ltd. (APL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Asston Pharmaceuticals Ltd. (APL) has a P/E ratio of 33.51x, which is above the benchmark median of 26.67x, a difference of +25.65%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Asston Pharmaceuticals Ltd. (APL) has a ROE of 50.56%, which is above the benchmark median of 11.23%, a difference of +350.22%. Asston Pharmaceuticals Ltd. (APL) has a ROCE of 42.64%, which is above the benchmark median of 13.17%, a difference of +223.77%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Par Drugs And Chemicals Ltd.	PAR	129.21	8.91	1.11	14.47	19.51
Lactose (India) Ltd.	LACTOSE	132.25	19.09	1.97	10.4	13.01
Godavari Drugs Ltd.	GODAVARI	133.1	32.03	1.69	10.64	10.13
Parnax Lab Ltd.	PARNAXLAB	124.68	13.3	1.24	13.24	13.79
Panchsheel Organics Ltd.	PANCHSHEEL	135.27	13.14	0.95	10.66	13.65

Asston Pharmaceuticals Ltd. (APL) has a P/E ratio of 33.51x compared with the displayed peer median of 13.3x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 50.56% compares with a peer median of 10.66% across the companies shown in the table. ROCE stood at 42.64% versus the displayed peer median of 13.65%, providing a capital-efficiency comparison. Asston Pharmaceuticals Ltd. (APL) has a market capitalisation of Rs 129.48 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Asston Pharmaceuticals

• Asston Pharmaceuticals Share Price is Rs 124.46 and up 4.99% from the previous close.
• The stock is trading close to its 52-week high and one-year high.
• Market capitalisation stands at Rs 129.48 crore for Asston Pharmaceuticals Share Price.
• P/E is 33.51, while ROE is 50.56% and ROCE is 42.64%.
• P/B is 1.96, EPS is 3.54 and book value is Rs 60.43.

About Asston Pharmaceuticals

Asston Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company profile available here is limited to this classification, so Asston Pharmaceuticals Share Price is best viewed through the verified market, valuation and peer data rather than a broader business description. For readers tracking Asston Pharmaceuticals Stock News, the key company identifiers remain the market cap, profitability ratios and current proximity to the yearly high. Asston Pharmaceuticals Share Price Today is therefore a market-data story first, with sector and valuation context adding the wider frame.

Frequently Asked Questions

Why is Asston Pharmaceuticals Share Price in focus today?

Ans. Asston Pharmaceuticals Share Price is in focus because it is trading near its 52-week high at Rs 124.46, after rising 4.99% from the previous close. The move is fact-based and confirmed by latest Univest data.

What is Asston Pharmaceuticals Share Price today?

Ans. Asston Pharmaceuticals Share Price Today is Rs 124.46. It is higher than the previous close of Rs 118.54 and reflects a Rs 5.92 increase in the morning session as of 22 October 2026 at 9:52 AM IST.

How close is Asston Pharmaceuticals Share Price to its 52-week high?

Ans. Asston Pharmaceuticals Share Price is trading close to its 52-week high. The current level of Rs 124.46 keeps it near that yearly high zone, which is the main reason the stock is drawing attention today.

What is the market capitalisation of Asston Pharmaceuticals?

Ans. Asston Pharmaceuticals has a market capitalisation of Rs 129.48 crore. That size should be viewed together with the stock’s valuation and profitability ratios, rather than as a quality measure on its own.

What does Asston Pharmaceuticals fundamental analysis show?

Ans. Asston Pharmaceuticals Fundamental Analysis shows a P/E of 33.51, P/B of 1.96, ROE of 50.56%, ROCE of 42.64%, EPS of 3.54 and book value of Rs 60.43. Dividend yield is 0.

How does Asston Pharmaceuticals compare with industry benchmarks?

Ans. Asston Pharmaceuticals Share Price sits alongside an industry median P/E of 26.67 and median P/B of 2.7. Its ROE and ROCE are well above the industry median, which adds context to the current valuation.

How does Asston Pharmaceuticals compare with peers?

Ans. Compared with peers such as Par Drugs And Chemicals and Lactose (India), Asston Pharmaceuticals has a higher P/E than some names, but its ROE and ROCE are stronger than several comparables in the same Pharmaceuticals & Drugs industry.

Where can I track Asston Pharmaceuticals Share Price live?

Ans. You can track Asston Pharmaceuticals Share Price on Univest for live price updates, market cap, valuation ratios, 52-week levels and peer comparison. That gives a single view of Asston Pharmaceuticals Share Price Today and related stock news.

Track Asston Pharmaceuticals Share Price on Univest

Use Asston Pharmaceuticals Ltd. (APL) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Asston Pharmaceuticals Share Price on Univest for live price updates, market capitalisation, key ratios, 52-week levels, peer context and company news. Univest also helps readers follow Asston Pharmaceuticals Share Price Today alongside valuation and sector comparisons in one place.